1699p -1.0 -0.1%
Last Trade - 26/02/21
| Market Cap | £1.20bn |
| Enterprise Value | £1.36bn |
| Revenue | £427.8m |
| Position in Universe | 392nd / 1807 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 30th Jun | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 167.3 | 218.1 | 271.8 | 327.3 | 406.5 | 427.8 | 472.1 | 500.3 | +20.7% | ||
| +43.4 | +6.6 | +47.9 | -15.8 | -22.4 | +4.7 | +349.4 | +8.48 | |||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
CVS Group plc is a holding company. The principal activities of the Company are to operate animal veterinary practices, veterinary diagnostic businesses, pet crematoria and an online pharmacy and retail business. Its segments are Veterinary Practice, Laboratories, Pet Crematoria and Animed Direct. The Veterinary Practice segment offers treatment for companion animals, equine and farm animals. The Laboratories segment provides diagnostic services to its veterinary practices and third-parties. Its laboratories provide Biochemistry, hematology, histology, serology and advanced allergy testing. The Pet Crematoria segment offers pet cremation services to its veterinary practices, third-party practices and directly to pet owners. The Animed Direct segment sells prescription and non-prescription drugs, pet food and other animal related products through its Website. It operates approximately 360 veterinary practices, four diagnostic laboratories, seven pet crematoria and an online dispensary.
| Last Annual | June 30th, 2020 |
| Last Interim | June 30th, 2020 |
| Incorporated | July 13, 2007 |
| Public Since | October 10, 2007 |
| No. of Shareholders: | n/a |
| No. of Employees: | 6,758 |
| Sector | Healthcare |
| Industry | Healthcare Providers & Services |
| Index | FTSE Aim All Share , FTSE Aim 100 , FTSE Intl-aim UK 50 , |
| Exchange | London Stock Exchange (AIM) |
| Shares in Issue | 70,692,515 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | C V S House Owen Road, DISS, IP22 4ER, United Kingdom |
| Web | https://www.cvsukltd.co.uk/ |
| Phone | +44 1379 644288 |
| Contact | Robin Alfonso (Chief Financial Officer, Executive Director) |
| Auditors | Deloitte LLP |
As of 26/02/21, shares in CVS are trading at 1699p, giving the company a market capitalisation of £1.20bn. This share price information is delayed by 15 minutes.
Shares in CVS are currently trading at 1699p and the price has moved by 55.87% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the CVS price has moved by 51.14% over the past year.
Of the analysts with advisory recommendations for CVS, there are there are currently 2 "buy" , 2 "hold" and 0 "sell" recommendations. The overall consensus recommendation for CVS is Buy. You can view the full broker recommendation list by unlocking its StockReport.
CVS is scheduled to issue upcoming financial results on the following dates:
CVS does not currently pay a dividend.
CVS does not currently pay a dividend.
CVS does not currently pay a dividend.
To buy shares in CVS you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in CVS are currently trading at 1699p, giving the company a market capitalisation of £1.20bn.
Here are the trading details for CVS:
Based on an overall assessment of its quality, value and momentum, CVS is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in CVS are currently priced at 1699p. At that level they are trading at 0.53% premium to the analyst consensus target price of 1,690.04.
Analysts covering CVS currently have a consensus Earnings Per Share (EPS) forecast of 0.56028 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like CVS. Over the past six months, the relative strength of its shares against the market has been 23.59%. At the current price of 1699p, shares in CVS are trading at 34.57% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The CVS PE ratio based on its reported earnings over the past 12 months is 0.136k. The shares are currently trading at 1699p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
CVS's management team is headed by:
Here are the top five shareholders of CVS based on the size of their shareholding:
